NFATc1 Regulates PD-1 Expression Upon T Cell Activation
Overview
Affiliations
PD-1 is a transmembrane protein involved in the regulation of immunological tolerance. Multiple studies have reported an association between high levels of PD-1 expressed on T cell surfaces and exhaustion in lymphocyte populations when challenged by chronic viral infections, such as HIV. By using model systems consisting of murine EL4 cells, which constitutively express PD-1, and primary murine CD8 T cells that express PD-1 upon T cell stimulation, we have identified two tissue-specific hypersensitive sites at the 5' CR of the PD-1 locus. Gene reporter assays in CD8 T cells have shown that one of these sites has robust transcriptional activity in response to cell stimulation. Cell treatment with the calcineurin inhibitor cyclosporine A or a NFAT-specific inhibitor led to a sharp reduction in PD-1 expression in the constitutive and inducible systems. Furthermore, analysis of this region by chromatin immunoprecipitation assay revealed NFATc1 binding associated with gene activation in EL4 and primary CD8 T cells. Mutation of the NFATc1 binding site in PD-1 reporter constructs resulted in a complete loss of promoter activity. Together, these results demonstrate that PD-1 gene regulation occurs in part via the recruitment of NFATc1 to a novel regulatory element at the pdcd1 locus and provides the molecular mechanism responsible for the induction of PD-1 in response to T cell stimulation.
Immune suppression sustained allograft acceptance requires PD1 inhibition of CD8+ T cells.
Miller-Handley H, Harper G, Pham G, Turner L, Shao T, Russi A J Immunol. 2025; 214(1):192-198.
PMID: 40073258 PMC: 11904129. DOI: 10.1093/jimmun/vkae007.
Hou P, Hu L, Zhang J, Zhou X, Xiao Y, Li L Commun Biol. 2025; 8(1):406.
PMID: 40069413 PMC: 11897324. DOI: 10.1038/s42003-025-07800-x.
Ye F, Huang J, Cheng X, Chen S, Huang F, Huang W Front Immunol. 2025; 16:1537466.
PMID: 40046051 PMC: 11880808. DOI: 10.3389/fimmu.2025.1537466.
Alhalabi O, Gouda M, Milton D, Momin H, Yilmaz B, Stephen B Cancer Med. 2025; 14(4):e70280.
PMID: 39945382 PMC: 11822648. DOI: 10.1002/cam4.70280.
Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers.
Strati A, Adamopoulos C, Kotsantis I, Psyrri A, Lianidou E, Papavassiliou A Int J Mol Sci. 2025; 26(3).
PMID: 39941003 PMC: 11818137. DOI: 10.3390/ijms26031235.